Product Information
DULOXETINE HCL DR 30 MG CAP is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1058 per EA under NDC 82009003010. Its NADAC has been published 184 times since Feb 15, 2023.
FDA first approved this application on Jun 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009003010
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DULOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203088FDA Approved
6/11/2014
TE Code
AB
On Market Since
6/11/2014
Pharmacological Classes
Price Statistics
The NADAC for DULOXETINE HCL DR 30 MG CAP has been published 184 times since Feb 15, 2023, and over the history we have for it it has risen 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1087 (Dec 13, 2023) |
| All-time low | $0.0696 (May 22, 2024) |
| 52-week high | $0.1058 |
| 52-week low | $0.0781 |
| Median price | $0.0838 |
| Average price | $0.0870 |
| Largest weekly change | -19.4% (Apr 17, 2024) |
| Weeks tracked | 184 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DULOXETINE HCL DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DULOXETINE HCL DR 30 MG CAP, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1058 per EA (NDC 82009003010), effective Aug 19, 2026.
How has the price of DULOXETINE HCL DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DULOXETINE HCL DR 30 MG CAP has risen 7.1%. It has been tracked across 184 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for DULOXETINE HCL DR 30 MG CAP?
Since Feb 15, 2023, the NADAC for DULOXETINE HCL DR 30 MG CAP has ranged from a low of $0.0696 (May 22, 2024) to a high of $0.1087 (Dec 13, 2023), with a median of $0.0838 per EA.
Are there cheaper alternatives to DULOXETINE HCL DR 30 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DULOXETINE HCL DR 30 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DULOXETINE HCL DR 30 MG CAP?
DULOXETINE HCL DR 30 MG CAP (NDC 82009003010) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.